Skip to the page

Data / Form D filings / ARUKA BIO, INC.

ARUKA BIO, INC.: Form D filings

ARUKA BIO, INC., a health care company in Princeton, NJ, filed 2 Form D notices with the SEC between 2023 and 2024. The latest, on April 24, 2024, reports $3.6 million sold of a $3.6 million offering to 7 investors.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
350 CARTER ROAD, Princeton, NJ, 08540
Phone
(732) 666-0166
Industry
Other Health Care
Entity type
Corporation
Incorporated in
Delaware
Year incorporated
2023
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
1991781

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Apr 24, 2024New notice$3,550,000$3,550,0007Apr 17, 2024sec.gov
Sep 7, 2023New notice$5,500,000$4,000$5,496,0001Aug 25, 2023sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
SIDDHARTHA MUKHERJEEExecutive Officer, Director
NARESHKUMAR JAIN, PH.D.Executive Officer, Director

Other health care companies in New Jersey that filed recently

Every Form D from the week of Apr 22, 2024 · All recent filings in New Jersey · All recent Other Health Care filings

Read from SEC EDGAR. Amount sold is what ARUKA BIO, INC. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.